Compare ADMA & NEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADMA | NEA |
|---|---|---|
| Founded | 2004 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.4B |
| IPO Year | N/A | N/A |
| Metric | ADMA | NEA |
|---|---|---|
| Price | $20.16 | $11.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $28.50 | N/A |
| AVG Volume (30 Days) | ★ 3.7M | 803.4K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.23% |
| EPS Growth | ★ 205.35 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $488,559,000.00 | N/A |
| Revenue This Year | $21.08 | N/A |
| Revenue Next Year | $25.98 | N/A |
| P/E Ratio | $23.56 | ★ N/A |
| Revenue Growth | ★ 27.63 | N/A |
| 52 Week Low | $13.50 | $9.20 |
| 52 Week High | $25.67 | $11.37 |
| Indicator | ADMA | NEA |
|---|---|---|
| Relative Strength Index (RSI) | 76.50 | 59.93 |
| Support Level | $18.73 | $11.44 |
| Resistance Level | $19.48 | $11.57 |
| Average True Range (ATR) | 0.74 | 0.09 |
| MACD | 0.33 | 0.00 |
| Stochastic Oscillator | 98.00 | 95.59 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
Nuveen AMT-Free Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and the alternative minimum tax applicable to individuals, by investing in an actively managed portfolio of tax-exempt municipal securities. The company invest in Transportation, Utilities, Healthcare, Education and Civics, and other sectors, with maximum investment in Transportation.